~~<i id='4379242A6A'><strike id='4379242A6A'><tt id='4379242A6A'><pre id='4379242A6A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

WSS

Notifications
- hotspot
Continuity nursing helped my family in our darkest PICU moments
log on

hotspot
focus
- hotspot
- knowledge
explore
knowledge
- | © No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

explore

comprehensive

author：hotspot 2025-09-27 12:34:19 - browse：44

Stock exchange — Drew Angerer/Getty Images

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.

The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than 20% in pre-market trading Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： India sets sights on home

hotspot

leisure time

focus

hotspot

entertainment

leisure time

SEATTLE--ASeattlepoliceofficershotapersononTuesdaywhowassuspectedofstabbinganotherpersondowntown,pol

WSS

Live blog: Hearing on CRISPR

Researchers separate signal from noise in heart wearable data

Norman Reedus' Daryl Dixon

How dance can help health care workers heal from trauma

The health care issue Democrats can’t solve: hospital reform

Life sciences investors close nearly $6 billion in new funds

explore

comprehensive

hotspot

How to save PrEP access — and even expand it

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Hepatitis C has a cure — but many Americans still lack access to it

New warning issued for rebooking air travel after delays, cancellations

The cancer drug shortage isn’t new — and neither are the solutions

Humans aren't the only ones with an imagination. Rats have it too

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Ebola public health emergency is over, WHO declares

Continuity nursing helped my family in our darkest PICU moments

Infant mortality in U.S. rose last year for first time in decades: CDC

leisure time

Plane’s emergency slide plummets from sky, hits Chicago home

Humans aren't the only ones with an imagination. Rats have it too

Researchers separate signal from noise in heart wearable data

How neuroscience research could help beat back brain cancer

New warning issued for rebooking air travel after delays, cancellations

Lindsay Lohan welcomes 1st child with husband Bader Shammas

focus

hotspot

entertainment

leisure time